Expected recognition of extraordinary income (gain on sale of investment securities)
Maruo Calcium Co.,Ltd.
1 listed security held by the Company (security name not disclosed)
To reduce strategic shareholdings and improve capital efficiency.
¥440 million (estimated), extraordinary income (gain on sale of investment securities)
Consolidated financial results for the third quarter of the fiscal year ending March 2027
The full-year consolidated earnings forecast for the fiscal year ending March 2027 is being reviewed, including other factors. The Company will promptly disclose any revision if one becomes necessary.
The sale is scheduled to take place from 29 October 2026 to 29 December 2026. The gain on the sale is expected to be recorded as extraordinary income in the consolidated financial results for the third quarter of the fiscal year ending March 2027. The full-year consolidated earnings forecast is being reviewed, including other factors.
If it becomes necessary to revise its earnings forecasts, the Company will promptly disclose the revision.
| Item | Details |
|---|---|
| Event name | Expected recognition of extraordinary income (gain on sale of investment securities) |
| Date of occurrence | 28 October 2026 (sale decided by the Board of Directors) |
| Subject Entity | Maruo Calcium Co.,Ltd. |
| Target Locations / Products | 1 listed security held by the Company (security name not disclosed) |
| Cause | To reduce strategic shareholdings and improve capital efficiency. |
| Amount of Impact on Business Performance | ¥440 million (estimated), extraordinary income (gain on sale of investment securities) |
| Accounting period in which recognized | Consolidated financial results for the third quarter of the fiscal year ending March 2027 |
| Impact on Earnings Forecast | The full-year consolidated earnings forecast for the fiscal year ending March 2027 is being reviewed, including other factors. The Company will promptly disclose any revision if one becomes necessary. |
| Outlook | The sale is scheduled to take place from 29 October 2026 to 29 December 2026. The gain on the sale is expected to be recorded as extraordinary income in the consolidated financial results for the third quarter of the fiscal year ending March 2027. The full-year consolidated earnings forecast is being reviewed, including other factors. |
| Planned follow-up disclosure | If it becomes necessary to revise its earnings forecasts, the Company will promptly disclose the revision. |
Items this document does not state (15)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.To reduce strategic shareholdings and improve capital efficiency.